Mangalam Drugs and Organics Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 76.56 | 102.28 | 97.34 |
| Operating Expense | 68.35 | 90.53 | 90.36 |
| Net Profit | 2.68 | 3.55 | 0.50 |
| Net Profit Margin | 3.50 | 3.47 | 0.51 |
| Earning Per Share | 1.70 | 2.24 | 0.32 |
| EBIDTA | 10.30 | 11.55 | 7.32 |
| Effective Tax Rate | TBA | 1.62 | -1.58 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 76.56 |
| Operating Expense | 68.35 |
| Net Profit | 2.68 |
| Net Profit Margin | 3.50 |
| Earning Per Share | 1.70 |
| EBIDTA | 10.30 |
| Effective Tax Rate | TBA |
Invest in Mangalam Drugs and Organics Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 368.59 | 372.25 | 451.07 |
| Operating Expenses Annual | 351.20 | 346.53 | 402.01 |
| Operating Profit Annual | 17.49 | 26.16 | 49.14 |
| Interest Annual | 13.92 | 12.96 | 11.16 |
| Depreciation | 14.63 | 10.99 | 10.25 |
| Net Profit Annual | -9.05 | 1.27 | 19.66 |
| Tax Annual | -2.01 | 0.94 | 8.08 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 368.59 |
| Operating Expenses Annual | 351.20 |
| Operating Profit Annual | 17.49 |
| Interest Annual | 13.92 |
| Depreciation | 14.63 |
| Net Profit Annual | -9.05 |
| Tax Annual | -2.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.04 | 1.95 | 0.58 |
| Cash Flow from Operations | 12.17 | 38.08 | 25.71 |
| Cash Flow from Investing | -17.91 | -22.17 | -27.33 |
| Cash Flow from Financing | 5.70 | -16.82 | 2.98 |
| Cash Flow at the End | 1 | 1.04 | 1.95 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 1.04 |
| Cash Flow from Operations | 12.17 |
| Cash Flow from Investing | -17.91 |
| Cash Flow from Financing | 5.70 |
| Cash Flow at the End | 1 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 4.75 | 7.03 | 10.89 |
| PBIT Margin (%) | 0.78 | 4.08 | 8.62 |
| PBT Margin (%) | 0.72 | 3.77 | 7.85 |
| Net PROFIT Margin (%) | -2.46 | 0.34 | 4.36 |
| Return On Networth / Equity (%) | -6.15 | 0.84 | 13.98 |
| Return On Networth /Employed (%) | 1.16 | 6.25 | 17.57 |
| Return On Assets (%) | -3.66 | 0.52 | 8.89 |
| Total Debt / Equity (X) | 0.66 | 0.58 | 0.56 |
| Asset Turnover Ratio (%) | 1.49 | 1.53 | 2.04 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 4.75 |
| PBIT Margin (%) | 0.78 |
| PBT Margin (%) | 0.72 |
| Net PROFIT Margin (%) | -2.46 |
| Return On Networth / Equity (%) | -6.15 |
| Return On Networth /Employed (%) | 1.16 |
| Return On Assets (%) | -3.66 |
| Total Debt / Equity (X) | 0.66 |
| Asset Turnover Ratio (%) | 1.49 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 155.04 | 151.85 | 140.49 |
| Total Current Assets Annual | 199.78 | 203.26 | 185.03 |
| Non Current Assets Annual | 157.36 | 154.72 | 143.39 |
| Total Shareholders Funds Annual | 142.35 | 151.96 | 150.56 |
| Total Assets Annual | 357.14 | 357.98 | 328.43 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 155.04 |
| Total Current Assets Annual | 199.78 |
| Non Current Assets Annual | 157.36 |
| Total Shareholders Funds Annual | 142.35 |
| Total Assets Annual | 357.14 |
EPS (INR)
Expected
1.69
Reported
1.70
Surprise
0.59%
Mar 2024
EPS beaten by 0.59%
Dec 2023
EPS beaten by 0.00%
